Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$10.29 USD
-0.05 (-0.48%)
Updated Sep 12, 2024 03:59 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Brokerage Reports
Green Thumb Industries Inc. [GTBIF]
Reports for Purchase
Showing records 1 - 20 ( 142 total )
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis MSO 2Q24 Recap: Fundamentals Intact Just Waiting for Federal Reform
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Debt Markets Sizzling, Verano/Cannabist Cook Up an Asset Acquisition
Provider: Ventum Capital Markets
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
2Q24 Preview: Best-in-Class Sustainable Cash Flow Generator
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
U.S. Cannabis Industry: 2Q24 Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
1Q24 Strong, Buys Back Shares Improves Profitability
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Sticking to its Rule of Thumb: Prudent Capital Allocation
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis ReHash: DEA Intends to Move to Schedule 3, Investors Not Pricing It In
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
US Cannabis Sector - The Smoke has Lifted! DEA Appears Poised to Publish Schedule III Ruling
Provider: Echelon Welath Partners
Analyst: Research Department